Benzinga | Nov 19, 2021 08:39AM EST

RBC Capital Maintains Sector Perform on Biogen, Lowers Price Target to $277

RBC Capital analyst Brian Abrahams maintains Biogen (NASDAQ:BIIB) with a Sector Perform and lowers the price target from $295 to $277.